Pascal and Francis Bibliographic Databases

Help

Permanent link : http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26097849

Export

Selection :

A Pooled Analysis of I nfections, Mal ignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease

Author
LICHTENSTEIN, Gary R1 ; RUTGEERTS, Paul2 ; SANDBORN, William J3 ; SANDS, Bruce E4 ; DIAMOND, Robert H5 ; BLANK, Marion5 ; MONTELLO, Jennifer5 ; TANG, Linda5 ; CORNILLIE, Freddy6 ; COLOMBEL, Jean-Frédéric7
[1] Division of Gastroenterology, Hospital of The University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
[2] University Department of Internal Medicine, Hospital Gasthuisberg, Leuven, Belgium
[3] Division of Gastroenterology, University of California San Diego, La Jolla, California, United States
[4] Division of Gastroenterology, Mount Sinai School of Medicine, New York, New York, United States
[5] Janssen Research & Development, Spring House, Pennsylvania, United States
[6] Janssen Biologics BV, Heverlee, Belgium
[7] Hopital Claude Huriez, Centre Hospitalier et Universitaire de Lille, Lille, France
Source

The American journal of gastroenterology. 2012, Vol 107, Num 7, pp 1051-1063, 13 p ; ref : 24 ref

ISSN
0002-9270
Scientific domain
Gastroenterology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Keyword (fr)
Adulte Antipsoriasique Antirhumatismal Entérite de Crohn Epidémiologie Gastroentérologie Immunodépresseur Immunomodulateur Infliximab Mortalité Pronostic Rectocolite ulcérohémorragique Traitement Maladie inflammatoire de l'intestin Anti-TNF-alpha Anticorps monoclonal Anticytokine Cytokine Facteur nécrose tumorale α Homme Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin
Keyword (en)
Adult Antipsoriatic agent Antirheumatic agent Crohn disease Epidemiology Gastroenterology Immunosuppressive agent Immunomodulator Infliximab Mortality Prognosis Ulcerative colitis Treatment Inflammatory bowel disease Anti-Tumor Necrosis Factor-alpha Monoclonal antibody Anticytokine Cytokine Tumor necrosis factor α Human Inflammatory disease Digestive diseases Intestinal disease
Keyword (es)
Adulto Antipsoriásico Antireumático Enteritis Crohn Epidemiología Gastroenterología Inmunodepresor Inmunomodulador Infliximab Mortalidad Pronóstico Rectocolitis ulcerohemorrágica Tratamiento Enfermedad inflamatoria intestinal Anti-TNF alfa Anticuerpo monoclonal Anticitoquina Citoquina Factor necrosis tumoral α Hombre Enfermedad inflamatoria Aparato digestivo patología Intestino patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B03 Other diseases. Semiology

Discipline
Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
26097849

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web